Posted 2/27/2024, 3:47:00 PM
Drug Makers Race to Develop Cheaper Rivals to Hot New Weight Loss Drugs
- The race is on between drug makers to compete with Novo Nordisk's Ozempic in the lucrative weight loss drug market
- Viking Therapeutics' new weight loss drug showed promising weight loss results in clinical trials, leading its stock to surge nearly 80%
- Investors are looking for cheaper alternatives to Ozempic and Eli Lilly's Zepbound, which have very high share prices
- Several other pharma companies like Regeneron, Amgen, and Zealand Pharma are developing their own weight loss drugs
- Zealand Pharma's liver disease drug that is also being tested for weight loss led to a 34% stock jump after positive trial results